|POZEN Inc. Announces Plans to Webcast Third-Quarter Earnings Conference Call|
CHAPEL HILL, N.C., Nov. 6 /PRNewswire/ -- POZEN Inc. (Nasdaq: POZN), a pharmaceutical development company with a portfolio of migraine products, today announced it plans to conduct a conference call following the release of financial results for the third quarter ended September 30, 2000. The company will release earnings before the market opens on Wednesday, November 8, 2000. John R. Plachetka, Pharm.D., POZEN's president and chief executive officer, and Matthew Czajkowski, chief financial officer, will host the conference call the same day at 11:00 a.m. Eastern Standard Time.
The conference call will be simulcast live on the Internet, and can be accessed by logging on to www.vcall.com or www.streetevents.com . A replay will be available at these sights, as well as on the Investor Relations section of the company's website, www.pozen.com , for seven days.
North Carolina-based POZEN Inc. is a pharmaceutical development company committed to building a portfolio of products with significant commercial potential in select therapeutic areas. The company's initial focus is migraine, where it has built a portfolio of four product candidates through a combination of innovation and in-licensing. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN."
POZEN is on the Internet at www.pozen.com .